Literature DB >> 32511559

Artificial intelligence-enabled rapid diagnosis of COVID-19 patients.

Xueyan Mei, Hao-Chih Lee, Kaiyue Diao, Mingqian Huang, Bin Lin, Chenyu Liu, Zongyu Xie, Yixuan Ma, Philip M Robson, Michael Chung, Adam Bernheim, Venkatesh Mani, Claudia Calcagno, Kunwei Li, Shaolin Li, Hong Shan, Jian Lv, Tongtong Zhao, Junli Xia, Qihua Long, Sharon Steinberger, Adam Jacobi, Timothy Deyer, Marta Luksza, Fang Liu, Brent P Little, Zahi A Fayad, Yang Yang.   

Abstract

For diagnosis of COVID-19, a SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is routinely used. However, this test can take up to two days to complete, serial testing may be required to rule out the possibility of false negative results, and there is currently a shortage of RT-PCR test kits, underscoring the urgent need for alternative methods for rapid and accurate diagnosis of COVID-19 patients. Chest computed tomography (CT) is a valuable component in the evaluation of patients with suspected SARS-CoV-2 infection. Nevertheless, CT alone may have limited negative predictive value for ruling out SARS-CoV-2 infection, as some patients may have normal radiologic findings at early stages of the disease. In this study, we used artificial intelligence (AI) algorithms to integrate chest CT findings with clinical symptoms, exposure history, and laboratory testing to rapidly diagnose COVID-19 positive patients. Among a total of 905 patients tested by real-time RT-PCR assay and next-generation sequencing RT-PCR, 419 (46.3%) tested positive for SARS-CoV-2. In a test set of 279 patients, the AI system achieved an AUC of 0.92 and had equal sensitivity as compared to a senior thoracic radiologist. The AI system also improved the detection of RT-PCR positive COVID-19 patients who presented with normal CT scans, correctly identifying 17 of 25 (68%) patients, whereas radiologists classified all of these patients as COVID-19 negative. When CT scans and associated clinical history are available, the proposed AI system can help to rapidly diagnose COVID-19 patients.

Entities:  

Year:  2020        PMID: 32511559      PMCID: PMC7274240          DOI: 10.1101/2020.04.12.20062661

Source DB:  PubMed          Journal:  medRxiv


  5 in total

1.  Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.

Authors:  Paul Hofman; Pascal Puchois; Patrick Brest; Hicham Lahlou; Daniel Simeon-Dubach
Journal:  Nat Med       Date:  2020-06       Impact factor: 53.440

2.  Proteinuria in COVID-19: prevalence, characterization and prognostic role.

Authors:  Justine Huart; Antoine Bouquegneau; Laurence Lutteri; Pauline Erpicum; Stéphanie Grosch; Guillaume Résimont; Patricia Wiesen; Christophe Bovy; Jean-Marie Krzesinski; Marie Thys; Bernard Lambermont; Benoît Misset; Hans Pottel; Christophe Mariat; Etienne Cavalier; Stéphane Burtey; François Jouret; Pierre Delanaye
Journal:  J Nephrol       Date:  2021-01-23       Impact factor: 3.902

3.  Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.

Authors:  Elmira R Vagapova; Timofey D Lebedev; Vladimir S Prassolov
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

Review 4.  The global response to the COVID-19 pandemic: how have immunology societies contributed?

Authors:  Faith Osier; Jenny P Y Ting; John Fraser; Bart N Lambrecht; Marta Romano; Ricardo T Gazzinelli; Karina R Bortoluci; Dario S Zamboni; Arne N Akbar; Jennie Evans; Doug E Brown; Kamala D Patel; Yuzhang Wu; Ana B Perez; Oliver Pérez; Thomas Kamradt; Christine Falk; Mira Barda-Saad; Amiram Ariel; Angela Santoni; Francesco Annunziato; Marco A Cassatella; Hiroshi Kiyono; Valeriy Chereshnev; Alioune Dieye; Moustapha Mbow; Babacar Mbengue; Maguette D S Niang; Melinda Suchard
Journal:  Nat Rev Immunol       Date:  2020-09-10       Impact factor: 53.106

5.  Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy.

Authors:  Elisa Russo; Pasquale Esposito; Lucia Taramasso; Laura Magnasco; Michela Saio; Federica Briano; Chiara Russo; Silvia Dettori; Antonio Vena; Antonio Di Biagio; Giacomo Garibotto; Matteo Bassetti; Francesca Viazzi
Journal:  J Nephrol       Date:  2020-10-06       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.